Sleep Apnea

The FDA has approved an expanded indication for a proprietary neurostimulation technology to treat those with severe obstructive sleep apnea.

Older adults that suffer with hypoxemia while sleeping showed decreased measures of cognition over a 5-year period, according to study results published in European Respiratory Journal.

WASHINGTON — Adults with central sleep apnea on adaptive servo-ventilation for 12 months had improved disease-specific quality of life, according to an abstract presented at the American Thoracic Society International Conference.

WASHINGTON — For patients with new moderate to severe obstructive sleep apnea, mandibular advancement device therapy reduced disorder severity, according to an abstract presented at the American Thoracic Society International Conference.

WASHINGTON — Black patients had decreased desaturation sensitivity during sleep recorded by pulse oximeters, according to research presented at the American Thoracic Society International Conference.

Obstructive sleep apnea may have an impact on retinal nerve fiber layer thickness and IOP, highlighting the importance of screening affected individuals for glaucoma, according to data published in the Journal of Glaucoma.

Healio has compiled the most-read news in pulmonology posted in May.

The FDA has granted conditional use with MRI to an implantable transvenous phrenic nerve stimulation therapy for adults with moderate to severe central sleep apnea.

People with obstructive sleep apnea, particularly those with other chronic conditions, had a significantly increased risk for developing long COVID after a SARS-CoV-2 infection compared with those without obstructive sleep apnea, data show.

WASHINGTON — Among patients with Parkinson’s disease, obstructive sleep apnea and decreased cognition, CPAP therapy improved cognitive function, according to an abstract presented at the American Thoracic Society International Conference.